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Available online 27 August 2016Background: Osteoporosis is a major public health problem associated with excess disability and mortality. It is
estimated that 50–70% of the variation in osteoporotic fracture risk is attributable to genetic factors. The purpose
of this hypothesis-generating study was to identify possible genetic determinants of fracture among African
American (AA) women in a GWAS meta-analysis.
Methods:Data on clinical fractures (all fractures except ﬁngers, toes, face, skull or sternum)were analyzed among
AA female participants in theWomen's Health Initiative (WHI) (N= 8155), Cardiovascular Health Study (CHS)
(N = 504), BioVU (N = 704), Health ABC (N = 651), and the Johnston County Osteoarthritis Project (JoCoOA)
(N = 291). Affymetrix (WHI) and Illumina (Health ABC, JoCoOA, BioVU, CHS) GWAS panels were used for
genotyping, and a 1:1 ratio of YRI:CEU HapMap haplotypes was used as an imputation reference panel. We
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234 K.C. Taylor et al. / Bone Reports 5 (2016) 233–242with fracture risk, adjusting for ancestry, age, and geographic region where applicable. We conducted a ﬁxed-ef-
fects, inverse variance-weighted meta-analysis. Genome-wide signiﬁcance was set at P b 5 × 10−8.
Results: One SNP, rs12775980 in an intron of SVIL on chromosome 10p11.2, reached genome-wide signiﬁcance
(P = 4.0 × 10−8). Although this SNP has a low minor allele frequency (0.03), there was no evidence for hetero-
geneity of effects across the studies (I2 = 0). This locus was not reported in any previous osteoporosis-related
GWA studies. We also interrogated previously reported GWA-signiﬁcant loci associated with fracture or bone
mineral density in our data. One locus (SMOC1) generalized, but overall there was not substantial evidence of
generalization. Possible reasons for the lack of generalization are discussed.
Conclusion: This GWASmeta-analysis of fractures in African Americanwomen identiﬁed a potentially novel locus
in the supervillin gene, which encodes a platelet-associated factor and was previously associated with platelet
thrombus formation inAfricanAmericans. If validated in other populations of African descent, these ﬁndings sug-
gest potential new mechanisms involved in fracture that may be particularly important among African
Americans.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).African American
Genetic association study1. Introduction
Osteoporosis is amajor public health problem that over a lifetime re-
sults in fractures in 40% of agingwomen (Melton et al., 1992). Although
the lifetime risk of fractures is slightly lower in nonwhite women, the
absolute risk is still substantial and may be rising (Farmer et al., 1984;
Baron et al., 1994; Baron et al., 1996). By 2025, 21% of all fractures in
the United States will occur in nonwhite women (Burge et al., 2007).
Importantly, the consequences of fractures may be greater among non-
white women. For example, African-American women who suffer a hip
fracture have longer hospitalization stays and aremore likely to be non-
ambulatory compared with European-American women (Furstenberg
and Mezey, 1987). Furthermore, mortality after a hip fracture is higher
among African-American than European-American women, pointing
to disparities in access to health care or differences in comorbidities
(Jacobsen et al., 1992). The Surgeon General's Report on Bone Health
and Osteoporosis noted the lack of information on ethnic and racial mi-
norities as a priority (United States Public Health Service Ofﬁce of the
Surgeon General, 2004).
Osteoporosis has a strong genetic component, with 25–85% of the
variation in osteoporosis-related traits (such as bone mineral density)
being attributable to genetic factors (Ralston, 2002; Ferrari, 2008). The
heritability of osteoporotic fracture (OF) has been estimated to be 0.5–
0.7 (Deng et al., 2002; Michaelsson et al., 2005). Genetic interactions
with both ethnicity and sexmay be an important source of heterogene-
ity (Johnson et al., 2009). To date, genome-wide association scans have
focused on bone mineral density (BMD) and osteoporosis in popula-
tions of primarily European or Asian descent. The largest relevant ge-
nome-wide association study (GWAS) to date is a meta-analysis
conducted by the Genetic Factors of Osteoporosis (GEFOS) consortium,
which included individuals of European and East Asian descent, and
identiﬁed 56 BMD-associated loci (Estrada et al., 2012). Fourteen of
these loci were also associated with fracture (any type) at a
Bonferroni-corrected level of signiﬁcance. Richards et al. identiﬁed an
additional gene that increased risk of fracture independent of bonemin-
eral density in a European sample (Richards et al., 2008). Two other
GWAS (Xiong et al., 2009; Guo et al., 2010a) and two genome-wide
copy number variation studies (Oei et al., 2014; Yang et al., 2008) in
have identiﬁed a few other putative fracture loci in Chinese and Europe-
an samples. In one published GWAS that used radiographic vertebral
fractures as the primary outcome of interest, one genome-wide signiﬁ-
cant locus was identiﬁed in the discovery sample, but did not replicate
(Oei et al., 2013).
Although some progress has been made, genes identiﬁed to this
point only explain a small portion of the total heritability of osteoporo-
sis-related traits, and it remains to be determined how these genes and
others affect risk of fracture in populations of African ancestry. More-
over, it has been argued that more genome-wide association studies
should focus on fracture (the most severe osteoporosis-related-phenotype) rather than BMD or other intermediate endpoints (Liu et
al., 2014).
Here, wemeta-analyzeGWAS data from 5 studies examining clinical
fracture in African-American women in an effort to identify potentially
novel genome-wide signiﬁcant loci. Because there is not a replication
sample within this study, the results are viewed as hypothesis-generat-
ing.We also examine the generalizability of previously discovered oste-
oporosis-related loci to this population of African-American women.
2. Methods
2.1. Subjects
Subjects for this study were African-American women from ﬁve
studies with information on clinical fracture: the Women's Health Ini-
tiative (WHI) (N = 8155) (Design of the Women's Health Initiative
clinical trial and observational study, 1998); the Cardiovascular Health
Study (CHS) (N = 504) (Fried et al., 1991); BioVU (N = 704) (Roden
et al., 2008); the Health ABC study (N = 651) (Newman et al., 2003);
and the Johnston County Osteoarthritis Project (JoCoOA, N = 291)
(Jordan et al., 2007). Women included in this study were over
50 years of age (for WHI, CHS, BioVU, and Health ABC), or over 45 (for
JoCoOA). Women from the WHI were part of the WHI-SHARe (SNP
Health Association Resource) project, which included randomly select-
ed African-American and Hispanic-American women who consented
to genetic research from both the observational study and the clinical
trial arms of the WHI. See Supplementary materials (Cohort Descrip-
tions) for additional descriptive information regarding each study. All
studies were cohort studies except BioVU,which deﬁned cases and con-
trols for fracture by linking a DNA repository to electronic medical
records.
2.2. Fracture phenotype
All studies measured fractures, excluding ﬁngers, toes, face, skull, or
sternum. Radiographic vertebral fractures were not included. Fractures
were incident after age 45 (for JoCoOA) or age 50 (WHI, CHS, BioVU,
and Health ABC). Fractures included in this analysis were adjudicated
in WHI, BioVU, and Health ABC, and self-reported in CHS and JoCoOA.
For WHI, hip fractures were centrally adjudicated. All other fractures
were centrally adjudicated for women in the clinical trial and for
women in the observational study enrolled at three BMD sites (Pitts-
burgh, Birmingham, Tucson/Phoenix). For Health ABC, Fractures were
adjudicated at the clinical centers based on radiograph conﬁrmation.
For BioVU, fracture phenotype was determined from medical records
in the BioVU database. For the other two studies (JoCoOA and CHS),
self-reported fractures were used. However, good reliability has been
found between self-reported fracture and adjudicated fracture (Chen
et al., 2004). More information about the ascertainment of fracture in
235K.C. Taylor et al. / Bone Reports 5 (2016) 233–242each of the studies can be found in the Supplementarymaterials (Cohort
Descriptions).2.3. Genotyping and quality control
Genotyping was performed using the Affymetrix Genome-Wide
Human SNP Array 6.0 (WHI), the Illumina 1M-Duo platform (Health
ABC, JoCoOA, BioVU), or the Illumina Human Omni1 Quad_v1 (CHS).
Hardy-Weinberg P-value inclusion criteria were set at N10−6 (WHI,
Health ABC, and BioVU), 10−5 (CHS), or 10−4 (JoCoOA). Call rates re-
quired for inclusion ranged from N90% (WHI) to N98% (BioVU, JoCoOA).
See Supplementary Table 1 for further quality control and genotyping
information for each cohort. A sensitivity analysis was conducted ex-
cluding SNPs with minor allele frequency (MAF) b0.15 from BioVU, be-
cause an association was detected between MAF and P-values in the
BioVU GWAS.2.4. Imputation
A 1:1 combination of the YRI and CEU HapMap (version 2) samples
provided the reference panel for imputation (see (Marchini and Howie,
2010) for a review of the advantages of usingmixed reference panels for
imputation). Imputation was done using MACH (WHI, JoCoOA, Health
ABC), BEAGLE v3.2.1 (CHS), or IMPUTE v2.1.2 (BioVU).2.5. Association analyses
The tests for single-SNP associations across the genome was ac-
complished through the application of survival analysis methods to
the observed data where possible (WHI, Health ABC), or logistic re-
gression (BioVU, CHS, JoCoOA). Survival analysis methods used
time to ﬁrst fracture (any fracture excluding ﬁngers, toes, face,
skull, or sternum) as the survival time. Fracture was treated as di-
chotomous (yes/no) for logistic regression analyses. The genotypes
for each SNP were coded as the number of copies of the minor allele
that each individual carries (additive genetic model), which has been
shown to have reasonable power under all genetic modes of inheri-
tance (Ziegler et al., 2008).
This ordinal genotype variable was entered into a logistic regression
or survival analysis model, and a P-value representing the signiﬁcance
of the association between the ordinal genotype variable and the out-
come was obtained. The trend test (for increasing minor allele count:
0, 1, or 2) provides a t-distributed statistic that does not rely on the
Hardy-Weinberg equilibrium (HWE) of the SNP (contrary to a simple
t-test based on allele counts), and assumes an additive genetic model
for associated alleles. The assessments of association between the im-
puted SNPs and fracturewere performed in R, using ProbABEL or surviv-
al packages.
We used a minimum model including adjustment for ancestry
(frappe ancestry estimates forWHI (Tang et al., 2005) or top 10principal
components for the other studies), age and geographic region (clinical
center), where applicable. In a secondary analysis in WHI, we also ran
amodel additionally adjusting for bodymass index (BMI), since obesity
is protective for fracture risk. InWHI, we also ran a fully adjustedmodel
which included age, geographic region, ancestry and a covariate for the
number of risk factors for fracture. The risk factors were identiﬁed in a
paper by Cauley et al. (Cauley et al., 2007) and for African-Americans in-
clude: height N 161.9 cm; higher than high school education; broken
bone at/after age 55 years (but before study enrollment); diabetes;
myocardial infarction; have any arthritis; use corticosteroids N2 years;
depressed (CES-D ormedication use); use sedatives/anxiolytic; parental
history of fracture; and greater than two falls during the last 12months
of follow-up or year before the fractures.2.6. Meta-analysis
METAL software was used for ﬁxed-effects inverse variance-weight-
ed meta-analysis (Willer et al., 2010). We applied genomic control on
the study-level results and at the meta-analysis stage (Devlin and
Roeder, 1999).We applied additional ﬁlters ofMAF N 0.02 andminor al-
lele count (MAC) N 10. Regional plots were created using LocusZoom
software (Pruim et al., 2010). Presence of heterogeneity across studies
was evaluated using the I2 statistic (Thorlund et al., 2012).
2.7. Multiple comparisons
The standard genome-wide signiﬁcance level is a P-value b 5×10−8.
Suggestive signiﬁcance was reported if the P-value was below the
threshold of b1 × 10−5.
2.8. Functional analysis
We performed an association analysis of genetically predicted gene
expression (GPGE) with fracture risk using the method MetaXcan
(http://dx.doi.org/10.1101/045260), with reference data from the
GTEx (Genotype-Tissue Expression) Project (Genotype-Tissue
Expression Consortium, 2013). GTEx is a large-scale effort where DNA
and RNA from multiple tissues were sequenced from almost 1000 de-
ceased individuals of European, African, and Asian ancestries. MetaXcan
is a gene-level approach that uses regression weights for the effects of
SNPs on gene expression derived from GTEx Project data and associa-
tion summary statistics from GWAS to test the association between
GPGE and GWAS phenotypes. MetaXcan is a meta-analysis extension
of PrediXcan (Gamazon et al., 2015), which performs the same gene-
based tests in individual-level data. Among the beneﬁts of this approach
are that it a) directly tests a biological mechanism, b) provides gene
level results, c) provides estimates of effect (which can suggest treat-
ments since GPGE that is positively correlated with risk may reduce
risk when knocked down), d) multiple testing for gene-based tests are
reduced, e) provides tissue-speciﬁc results, and f) can study GPGE-dis-
ease relationships in consortia with large sample sizes where individu-
al-level data are not available to the coordinating group.
We scanned over 40 tissues from the GTEx Project using the entire
set of summary statistics from the GWAS. Sample sizes for the GTEx ref-
erence data are presented in Supplementary Table 2, and only tissues
with at least 100 observationswere used here. This software and all pre-
dictionmodels necessary to apply to new datasets are publicly available
on https://github.com/hakyimlab/PrediXcan.
2.9. Generalization analysis
To test for generalization of previously reported SNP associations
with bone density-related traits, we applied the framework of Heller
et al. (Heller et al., 2015). The generalization null hypothesis states
that a SNP is not associated with the outcome in the discovery study,
the generalization study, or both, and is rejected if there is enough evi-
dence that the SNP is associatedwith the traits in both studies. Under di-
rectional control, associations that have consistent directions of effects
in both studies are also of interest. For each reported analysis (each pub-
lished manuscript and trait), a false discovery rate (FDR)-controlling
multiple testing adjustment procedure was applied to control multiple
testing of the generalization null hypothesis at the 0.05 level. When ef-
fect alleles and directions of associations were available, we calculated
directional FDR r-values to decide whether an association generalized.
The r-value is similar in interpretation to an adjusted P-value, and rep-
resents the probability that generalizations with r-values smaller than
the given r-value are false. When the trait reported in the “discovery
study” (the study initially reporting the association) was bone mineral
density (BMD), an associationwas considered as having a consistent di-
rection of association if it had different signs in the discovery study and
236 K.C. Taylor et al. / Bone Reports 5 (2016) 233–242in our study. Otherwise, we required the same effect direction. For two
analyses effect alleles were not available (results reported by Zhang et
al. from an investigation of SNP-trait associations known to them at
the time (Zhang et al., 2014a)), and a single association reported by




The sample size for each cohort ranged from 291 (in JoCoOA) to
8155 (in WHI), and the number of fractures ranged from 35 (JoCoOA)
to 313 (WHI) (Table 1). In all, there were 10,305 women included in
themeta-analysis and a total of 540 fractures. The cumulative incidence
of adjudicated fractures during follow-up varied from 0.038 (WHI) to
0.077 (BioVU) to a maximum of 0.135 (Health ABC); the cumulative in-
cidence of self-reported fractures was 0.10 in CHS and 0.12 in JoCoOA.
The incidence rate for adjudicated fractures in WHI was 4.0 fractures/
1000 person-years; in Health ABC the rate was 12.4 per 1000 person-
years.
3.2. Results of meta-analysis
Themeta-analysis revealed one genome-wide signiﬁcant SNP (Table
1; Fig. 1). There was no evidence of residual confounding by population
stratiﬁcation according to the quantile-quantile plot of observed vs. ex-
pected P-values (λ= 0.983, Fig. 2). The genome-wide-signiﬁcant SNP,
rs12775980 (minor allele frequency= 0.03, P= 4.0 × 10−8), is located
in an intron of the gene supervillin (SVIL) on chromosome 10. It was ge-
notyped on the Affymetrix 6.0 chip but not Illumina 1M or the
OmniQuad. Therefore it was genotyped in the largest cohort (WHI)
but imputed for the other cohorts (imputation quality scores: 0.98 in
BioVU; 0.97 in Health ABC; 0.96 in JoCoOA; and 0.77 in CHS). In HapMap
the minor allele frequency for this SNP is 0.066 in CEU (CEPH-Utah),
0.022 in YRI (Yoruban), and 0.052 in ASW (African ancestry individuals
from Southwest USA). After conducting a sensitivity analysis excluding
BioVU SNPs with MAF b 0.15 (to reduce the chance of type I errors; see
Section 2.3), the P-value for this SNP was still GWA-signiﬁcant (P =
4.6 × 10−8). The regional plot shows that rs12775980 is in linkage dis-
equilibrium (LD) with several other nearby SNPs analyzed in the meta-
analysis (Fig. 3). The other notable SNPs in this regional plot (based on
small P-values) include rs7893141 (P = 1.36 × 10−7), rs17768169
(P = 1.58 × 10−7) and rs12767247 (P = 1.36 × 10−5); rs12771815
(P = 3.53 × 10−4) and rs11819549 (P = 7.81 × 10−4), all of which
are intronic.
We examined whether this SNP (rs12775980) was signiﬁcantly as-
sociated with either femoral spine BMD or lumbar spine BMD among
women in the GEFOS study, using their publicly available GWAS results
(http://www.gefos.org/?q=content/data-release) (Estrada et al.,
2012). The SNP was not signiﬁcantly associated with either phenotype
in thismeta-analysis of cohort studies (with individuals primarily of Eu-
ropean and east Asian ancestry).Table 1
Sample size and number of clinical fractures for the ﬁve studies included in a meta-analysis of
Study N Number of frac
BioVU 704 54
Cardiovascular Health Study 504 50
Health ABC 651 88
Johnston County Osteoarthritis Project 291 35
Women's Health Initiative 8155 313
Total 10,305 540
a SD= standard deviation.
b Mean follow-up time is provided for studies that conducted survival analysis of clinical fraThere were also several loci with suggestive signiﬁcance
(P b 1.0 × 10−5) (Table 1; Fig. 1). Regional plots for these are provided
in the Supplementary materials (Supplementary Figs. 1–8). For three of
these SNPs, there was evidence of moderate (rs1228431, rs7547923) or
substantial (rs2275731) heterogeneity of effects among the 5 studies,
according to the I2 statistic.
3.3. Additional secondary analyses in WHI
In WHI, we were also able to run a fully adjusted model which in-
cluded a term for the number of fracture risk factors (see list in
Section 2.5). A disadvantage of this approach is that it assigns equal
weight to each of the risk factors. However, the WHI results using the
minimally adjustedmodel and the fully adjustedmodelwere notmean-
ingfully different for the top results, and the results from the minimally
adjusted model are presented in the meta-analysis to maintain consis-
tency with the other cohorts.
After running themeta-analysis, we observed that among the top re-
sults with suggestive signiﬁcance, three of the loci are related to BMI.
PTER has been reported as a genomewide-signiﬁcant ﬁnding for morbid
obesity (Meyre et al., 2009); MOGAT2 is a gene involved in dietary fat
absorption and was associated with HDL cholesterol levels in a GWAS
(Willer et al., 2013); and LUZP2was associated with the ratio of visceral
adipose tissue to subcutaneous adipose tissue (rs16912285) (Fox et al.,
2012). For PTER andMOGAT2, the SNPs identiﬁed in our study were not
in LD with the SNPs discovered in previous GWAS. But for LUZP2, both
analyses may be tagging the same signal (R2 between rs7113850 and
rs16912285 = 0.42 in CEU). The risk allele for increased adiposity in
the prior study (rs16912285) was the minor allele (MAF = 0.10), and
in the present study, the allele associatedwith decreased risk of fracture
for rs7113850 was also the minor allele (MAF = 0.22).
In WHI, we examined whether adjusting for BMI might attenuate
the results for these three loci. Adjusting for BMI had very little effect
on the results (P-values and effect estimates) for all three loci; therefore,
we did not pursue this analysis with the remaining cohorts, since WHI
represents nearly 80% of the sample.
3.4. MetaXcan analysis
For this analysis, which examined the association between geneti-
cally predicted gene expression (GPGE) in speciﬁc tissues with fracture
risk, the most highly associated genes and tissues (P b 1.0 × 10−5) are
presented in Supplementary Table 4 (P b 1.0 × 10−5). We also speciﬁ-
cally examined the results for any associations between GPGE and frac-
ture risk for the 9 loci shown in Table 2. Of these, genetically predicted
expressions of RAB31, SLC40A1, PTER,DOK6, andCOL7A1werenominally
associated (P b 0.05) with fracture risk in at least one tissue type. Nota-
bly, genetically predicted expression of PTER in skeletal muscle was in-
versely associated with fracture risk (Z-score = −2.02; P = 0.043),
and genetically predicted expression of COL7A1 in the tibial nerve was
positively associated with fracture risk (Z-score = 2.30; P = 0.022).
For the other genes, nominally signiﬁcant associations were identiﬁed
in brain tissue (RAB31 and DOK6) and ovary (SLC40A1).clinical fractures among 10,305 unrelated African-American women.
tures Mean age (SDa) Mean follow-up timeb (years) (SD)
65.1 (10.1) n/a
73.1 (5.7) n/a
73.4 (2.9) 8.5 (3.3)
63.8 (9.6) n/a
61.6 (7.0) 10.8 (3.0)
ctures.
Fig. 1.Manhattan plot of a GWAS meta-analysis of clinical fracture in up to 10,302 African-American women.
237K.C. Taylor et al. / Bone Reports 5 (2016) 233–2423.5. Generalization of loci previously reported in osteoporosis-related
GWAS
We examined the generalization of SNPs for loci reported in previ-
ous GWA studies ormeta-analyses for bonemineral density or other os-
teoporosis-related traits in populations of primarily European or Asian
descent (Estrada et al., 2012; Richards et al., 2008; Xiong et al., 2009;Fig. 2. Quantile-quantile plot comparing the distribution of observed vs. expected – log P-
values for a GWAS meta-analysis of clinical fracture in up to 10,302 African-American
women.Zhang et al., 2014a; Kou et al., 2011; Styrkarsdottir et al., 2008;
Rivadeneira et al., 2009; Paternoster et al., 2010; Duncan et al., 2011;
Kiel et al., 2007; Zheng et al., 2013; Medina-Gomez et al., 2012; Guo et
al., 2010b; Koller et al., 2010; Hsu et al., 2010; Hwang et al., 2013).
Three of the studies included some individuals (b1000) of African de-
scent, either in their discovery or replication sample (Xiong et al.,
2009; Zhang et al., 2014a; Koller et al., 2010). There were 62 indepen-
dent regions (at least 1 MB apart) identiﬁed in the collective list of all
GWA-signiﬁcant loci reported for osteoporosis-related traits in the
GWAS catalog (as of 7/16/2015). Out of 140 associations in 62 loci,
one association generalized: rs227425 in SMOC1 (r-value = 0.02, AA
P-value = 0.01), which was initially reported as a BMD locus by
Zhang et al. (Zhang et al., 2014b). A few other associationswere border-
line signiﬁcant: rs7117858 (r-value = 0.054, AA P-value = 0.006) and
rs7108738 (r-value = 0.059, AA P-value = 0.004), both near LUZP2;
and rs12272917 (r-value = 0.092, AA P-value = 0.01) in PPP6R3.
While it is surprising that rs227425 (SMOC1) generalized while
rs7117858 and rs7108738 did not (the latter two had lower P-values
than rs227426 in the AA cohort), this is because the number of general-
ization tests was higher in the generalization analyses that included
rs7117858 and rs7108738. The full results for all previously published
SNPs across the 62 loci are given in the Supplementary materials (Sup-
plementary Table 3).4. Discussion
4.1. Summary of ﬁndings
In this GWASmeta-analysis of fracture in African American women,
we identiﬁed one potentially novel locus, SVIL, and eight other sugges-
tive loci. We also investigated generalization for 62 genome-wide sig-
niﬁcant loci previously identiﬁed for bone mineral density or other
osteoporosis-related phenotypes in populations of primarily European
or Asian descent. One locus (SMOC1) generalized, and two others
(LUZP2 and PPP6R3) were suggestive.
Fig. 3.Regional plot (LocusZoom) for the SVIL locus. The diamond (shown in purple) is themost statistically signiﬁcant SNP in the region, according to P-value. All other SNPs are shown as
circles. The colors represent thedegreeof linkagedisequilibriumwith the index SNP (see R2 values on the left of theﬁgure.) For additional documentation, please see http://locuszoom.sph.
umich.edu/locuszoom/.
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The SVIL locus is a promising candidate gene for fracture and other
osteoporosis-related phenotypes based on its biological function. The
tissue expression pattern of SVIL revealed that it is most highly
expressed in skeletal muscle (the Genotype-Tissue Expression Project;
gtexportal.org) (Supplementary Fig. 9) (Genotype-Tissue Expression
Consortium, 2013). The supervillin protein is a platelet-associated factor
that plays a role in thrombus formation, and human SVIL variants have
already been shown to be associated at a genomewide-signiﬁcant
level with platelet thrombus formation in African Americans, but not
European Americans (Edelstein et al., 2012). This could potentially ex-
plain why this association was not detected in previous GWAS, which
mostly had European-American or European participants. The same
study also showed that several SVIL SNPs are signiﬁcantly associated
with SVILmRNA expression, and that SVILmRNA expression is inversely
associated with platelet thrombus formation, suggesting an inhibitory
effect. Higher SVIL mRNA levels would thus be expected to result in
lower platelet function. As injection of platelets at a fracture site hasTable 2
Top loci (P b 1.0 × 10−5) associated with clinical fracture in African-American women.
Top SNP in regiona Chr Positionb Effect allele EAFc P Ef
rs12775980 10 29,899,862 A 0.03 4.0 × 10−8 2.
rs11872467 18 9,838,002 A 0.11 1.1 × 10−6 2.
rs10931422 2 190,084,680 T 0.07 2.5 × 10−6 1.
rs2275731 10 16,566,846 A 0.37 3.5 × 10−6 1.
rs7113850 11 24,151,165 G 0.78 4.7 × 10−6 1.
rs12284314 11 75,116,572 C 0.21 5.0 × 10−6 1.
rs7547923 1 180,976,245 A 0.03 6.5 × 10−6 3.
rs12606715 18 65,062,093 C 0.42 8.0 × 10−6 1.
rs6792156 3 48,629,942 C 0.46 9.3 × 10−6 1.
a SNP with lowest P-value within a 1 megabase region. See corresponding LocusZoom plots
b HapMap phase 2, release 22, build 36.
c EAF = effect allele frequency.
d Effect ratio refers to the meta-analyzed hazard ratios (fromWHI and Health ABC) and odd
e CI = conﬁdence interval.
f WHI, HealthABC, CHS, BioVU, JoCoOA.
g I2 = heterogeneity statistic.been reported to aid in fracture healing (Sampson et al., 2008), the
SVIL SNP might indicate a new pathway involved in fracture. Since the
minor allele of SVIL variant rs12775980 was associated with increased
risk of fracture (OR = 2.12), it could be reasoned that the variant may
be associated with increased SVIL mRNA levels, resulting in decreased
platelet thrombus formation and higher vulnerability to fracture. Al-
though this association is therefore biologically plausible, replication
in larger studies is especially warranted considering the low minor al-
lele frequency of the SNP (0.03 in AAs). This SNP may contribute to
the lower fracture rate and higher BMD observed in AA, since the frac-
ture-increasing allele is less frequent in individuals of African descent
(MAF = 0.022 in YRI vs. 0.066 in CEU).
Some research suggests that obesity may be a protective factor for
fracture; likewise, adiposity was recently shown to be causally related
to increased bone mineral density in a Mendelian randomization
study of BMI loci and BMD in children (Kemp et al., 2016). Three of
our top loci (PTER,MOGAT2, and LUZP2) have been previously associated
with obesity or obesity-related traits, though only for LUZP2 does the
signal appear to be the same for both traits (in this case, visceral adiposefect ratiod (95% CIe) Directions of effectf N I2(g) Nearest gene
12 (1.61, 2.79) ++++− 10,302 0 SVIL (intron)
29 (1.64, 3.20) ?++++ 2147 0 RAB31 (intron)
62 (1.33, 1.97) ++++− 10,302 0 SLC40A1(nearby)
36 (1.21, 1.53) +−+++ 10,302 67.9 PTER (intron)
54 (1.29, 1.83) +++++ 10,302 0 LUZP2 (nearby)
39 (1.21, 1.60) ++−+− 10,302 43.7 MOGAT2 (intron)
22 (1.94, 5.39) ?++++ 2147 35.8 NPL (nearby)
32 (1.18, 1.49) +++++ 10,302 0 DOK6 (nearby)
34 (1.17, 1.53) +++++ 10,302 0 COL7A1 (nearby)
.
s ratios (from BioVu, CHS and JoCoOa).
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risk were virtually unchanged after adjusting for BMI, suggesting an in-
dependent effect on fracture. For example, these genes may affect bone
morphology, density or quality.
4.3. Generalization of loci identiﬁed in prior studies
Overall, only a small fraction of previously reported SNP associations
with bone-density related traits generalized in this population of AA
women. SMOC1, the only locus which generalized at a statistically sig-
niﬁcant level, is a bone morphogenetic protein (BMP) antagonist
(Thomas et al., 2009) and plays an important role in limb development
(Okada et al., 2011; Rainger et al., 2011) and osteoblast differentiation
(Choi et al., 2010).
Lack of generalization could be due to several reasons. First, different
traits were used in the previously reported analyses (“discovery stud-
ies”) and our analysis. Other studies have demonstrated that a minority
of GWA-signiﬁcant BMD lociwere also associatedwith fracture (Estrada
et al., 2012; Guo et al., 2012). In the large GEFOS study, fourteen of the
56 BMD loci (25%) were also associated with fracture (any type) at a
Bonferroni-corrected level of signiﬁcance in their meta-analysis; and
this was within the same dataset (Estrada et al., 2012). In a study of
700 Chinese Han subjects, 350 hip fracture cases and 350 controls, 4 of
23 previously identiﬁed BMD-related lociwere associatedwith fracture,
though only one remained signiﬁcant after correction for multiple test-
ing (Guo et al., 2012). In our case, we attempted to replicate BMD-asso-
ciated loci for risk of fracture in individuals of African ancestry; given the
results discussed above, it is unclear how much replication should be
expected. Second, there are different linkage disequilibrium (LD) pat-
terns between the populations in the discovery studies and this study
of AAwomen, and therefore the best tag SNP for the causal SNP is differ-
ent between populations. Third, it is possible that some associations are
false positive in the discovery study; or that the true effect size is smaller
than reported in the discovery study due to the winner's curse, and our
study did not have enough power to detect the true effect size. Finally,
lack of power could be also due to lower MAF in the AAs compared to
the discovery study population, and low powermay also result from ge-
netic heterogeneity within the AA population.
4.4. Challenges and limitations
There are several sources of heterogeneity both within and across
the 5 studies used in this analysis which may have limited our power
to discover novel associations with fracture. In addition to the inherent
genetic heterogeneity of African-American populations, especially con-
sidering that European admixture among AA ranges widely and the dif-
ferent geographic regions represented among the studies, there were
different methods of ascertaining fracture (adjudicated vs. self-report)
and different modeling strategies (survival analysis vs. logistic regres-
sion) resulting from differences in how the data were collected. Effects
of two loci (MOGAT2 and PTER) were meaningfully heterogeneous
across the 5 studies according to the I2 statistic and inconsistent direc-
tions of effect (Table 2). Heterogeneity may indicate different patterns
of LD between typed markers and causal variants, deviation of HWE,
and gene-environment interactions that vary among studies
(Ioannidis et al., 2007; Salanti et al., 2005), in addition to the reasons
given above.
Lowminor allele frequencies for some of the top SNPs may have led
to spurious results, particularly in the smaller cohorts. However, rare
variants and “goldilocks” (MAFbetween1% and5%) variantsmaybe im-
portant contributors to the total genetic risk for fracture. A recent
whole-genome sequencing study of BMD identiﬁed novel noncoding
conserved variants with low MAF but with large effect size (Zheng et
al., 2015), similar to the SVIL locus. In addition, a genome-wide study
of copy number variants identiﬁed a rare deletion associated withfracture in a European sample, again highlighting the potential impor-
tance of rare variants to fracture risk (Oei et al., 2014).
The causes of fractures in this meta-analysis were not identiﬁed. It
may be rationalized that genetic susceptibility to fracture may play a
more important role in some fractures (e.g., minor falls) than others
caused by more severe trauma (e.g., fractures caused by car accidents).
However, low BMD has been associated with risk of trauma-related
fractures, demonstrating that genetic susceptibilitymay also play an im-
portant role in these fractures (Mackey et al., 2007). Finally, vertebral
fractures were not included in this analysis because they were not al-
ways available; this may have inﬂuenced the results.
4.5. Conclusion
In the only genome-wide association scan of clinical fracture among
exclusively African Americans to date, we have also identiﬁed one po-
tentially novel locus and several suggestive loci that may contribute to
the lower fracture rate amongAA. Because this was a hypothesis-gener-
ating study, replication is needed in other populations of African descent
to conﬁrm these ﬁndings.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bonr.2016.08.005.
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